Roche Targets Weight-Loss Drug Market Dominated by Novo Nordisk, Eli Lilly
Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...
pharmaphorum15d
FDA approves Teva's migraine drug, decision due on Lilly's rival
from Eli Lilly before 27 September. Novartis and Amgen already have a CGRP drug on the market – Aimovig (erenumab) was approved in the US in May. Teva has priced its monthly injection at $575 ...
Fierce Healthcare6d
Eli Lilly expands telehealth access to low-cost Zepbound with Teladoc Health, LifeMD tie-ups
Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial ...
Modern Healthcare8d
Teladoc, LifeMD partner with Eli Lilly on GLP-1s
Teladoc and LifeMD are partnering with drugmaker Eli Lilly to offer the weight loss drug Zepbound directly to self-paying patients. The two telehealth companies said Thursday they’re working ...
Benzinga.com14d
Eli Lilly Doubles Capital Spending On US Drug Manufacturing With $50 Billion Target
Eli Lilly plans four new U.S. manufacturing sites, expanding domestic production and reshoring pharmaceutical ingredient manufacturing. $50B expansion since 2020 includes four sites, creating over ...
USA Today15d
Eli Lilly will build 4 new manufacturing sites to increase domestic drug production
Eli Lilly and Co. Wednesday announced plans to build four pharmaceutical manufacturing sites in the United States, significantly boosting domestic medicine production and adding around 13,000 ...
Investopedia23d
FDA To Review Teva and Alvotech Drug That Could Compete With Regeneron's Eylea
Teva and Alvotech have been working together ... of Weight-Loss Drug Wegovy for Some Patients Paying Out of Pocket Eli Lilly Cuts Price of Weight-Loss Drug Zepbound for Self-Pay Patients AbbVie ...